12 Health Care Stocks Moving In Monday's Pre-Market Session
I'm LongbridgeAI, I can summarize articles.In Monday's pre-market session, several health care stocks saw significant movement. Alpha Tau Medical (DRTS) rose 13.5% to $9.66, while Zhengye Biotechnology (ZYBT) increased by 12.69% to $1.07. Valneva (VALN) shares climbed 11.98% to $6.26, and Exagen (XGN) rose 11.88% to $3.3. Conversely, First Tracks (TRAX) fell 13.2% to $16.97, and Aditxt (ADTX) dropped 12.88% to $0.1. Other notable losers included Apimeds Pharmaceuticals (APUS) and Longeveron (LGVN), which saw declines of 10.7% and 8.9%, respectively.
Gainers
- Alpha Tau Medical (NASDAQ:DRTS) stock moved upwards by 13.5% to $9.66 during Monday's pre-market session. The company's market cap stands at $721.8 million.
- Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 12.69% to $1.07. The market value of their outstanding shares is at $44.9 million.
- Valneva (NASDAQ:VALN) shares increased by 11.98% to $6.26. The market value of their outstanding shares is at $530.0 million.
- Exagen (NASDAQ:XGN) shares rose 11.88% to $3.3. The market value of their outstanding shares is at $71.2 million. As per the news, the Q1 earnings report came out today.
- Decoy Therapeutics (NASDAQ:DCOY) stock increased by 11.18% to $6.36. The market value of their outstanding shares is at $3.0 million. As per the news, the Q1 earnings report came out yesterday.
- BridgeBio Oncology (NASDAQ:BBOT) shares moved upwards by 10.31% to $8.45. The company's market cap stands at $613.6 million.
Losers
- First Tracks (NASDAQ:TRAX) stock decreased by 13.2% to $16.97 during Monday's pre-market session. The company's market cap stands at $678.9 million.
- Aditxt (NASDAQ:ADTX) shares fell 12.88% to $0.1.
- Apimeds Pharmaceuticals (AMEX:APUS) stock decreased by 10.7% to $1.35. The company's market cap stands at $19.0 million.
- Longeveron (NASDAQ:LGVN) shares declined by 8.9% to $0.77. The company's market cap stands at $24.7 million.
- Certara (NASDAQ:CERT) stock decreased by 8.25% to $5.79. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q1 earnings report came out today.
- XORTX Therapeutics (NASDAQ:XRTX) shares declined by 7.89% to $2.57. The market value of their outstanding shares is at $4.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.